France· FR:65407392
BEXAROTENE CIPLA 75 mg, capsule molle
A medicinal product containing bexarotène, registered in France by CIPLA EUROPE (BELGIQUE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BEXAROTÈNE
- Manufacturer
- CIPLA EUROPE (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302411721 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 100 capsulesEUR 292.81
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bexarotène in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBexarotene AmdipharmAmdipharm Limited
- United StatesbexaroteneActavis Pharma, Inc.
- NorwayBexarotene AmdipharmAmdipharm Limited
- SpainBEXAROTENO CIPLA 75 MG CAPSULAS BLANDAS EFGCipla Europe N.V.
- SwedenBexarotene Amdipharm 75 mg Kapsel, mjukAmdipharm Limited
- PolandTargretinH.A.C. Pharma
- IrelandTargretin 75 mg soft capsulesH.A.C Pharma
- CzechiaTARGRETINH.A.C. Pharma, Caen
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Bexagia
- Germany · Bexaroten Cipla
- Denmark · Bexarotene
- Spain · Bexaroteno Cipla
- Finland · Bexarotene Amdipharm
- United Kingdom (Northern Ireland) · Bexarotene Genus Pharmaceuticals Ltd.
- Iceland · Targretin
- Italy · Bexarotene Cipla
- Liechtenstein · Targretin
- Norway · Bexarotene Amdipharm, Targretin
- Sweden · Bexarotene Amdipharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bb4df1ee-e686-4eac-bba8-fcec73cb3a27 GET /v1/drugs/bb4df1ee-e686-4eac-bba8-fcec73cb3a27?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65407392",
"date_amm": "2021-10-27",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "BEXAROTÈNE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "capsule molle",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about bexarotène.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.